B. Closure of beta-cell ATP-sensitive potassium channels causing depolarization, calcium influx and insulin release
Why this is correct
Sulfonylureas bind the SUR1 regulatory subunit of ATP-sensitive potassium (KATP) channels on pancreatic beta cells. Channel closure depolarizes the membrane, opens voltage-gated calcium channels and triggers insulin granule exocytosis. Since the released insulin is endogenous, C-peptide is elevated. Drug-associated hypoglycemia can recur, especially with long-acting drugs or kidney dysfunction; supportive glucose and, when appropriate, octreotide can suppress recurrent beta-cell insulin secretion.
Why each option is correct or incorrect
Opening KATP channels hyperpolarizes beta cells and tends to suppress insulin secretion.
Correct: sulfonylureas close KATP channels, causing depolarization, calcium entry and insulin secretion.
Sulfonylureas act primarily on pancreatic insulin secretory machinery, not by binding muscle insulin receptors.
Proximal tubular glucose transport inhibition is the action of SGLT2 inhibitors.
High-yield notes
- Sulfonylureas bind SUR1 and close beta-cell KATP channels.
- Endogenous insulin excess elevates both insulin and C-peptide.
- Octreotide may help prevent recurrent sulfonylurea hypoglycemia in suitable cases.
Insulin and C-peptide are both elevated in sulfonylurea-related hypoglycemia.
A negative sulfonylurea screen is essential before attributing endogenous hyperinsulinemia solely to insulinoma.